Michael Gnant, MD of University of Vienna @MedUni_Vienna discusses the impact of multigenomic assays in premenopausal patients and those with node-positive breast cancer.
Read here: https://dailynews.ascopubs.org/do/10.1200/ADN.20.200006/full/?cid=DM4922&bid=42056373&
Advertisement